{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:38Z","timestamp":1788273638634,"version":"build-2803163510"},"reference-count":124,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000063","name":"Office of Dietary Supplements","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpet.2025.103522","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:53:40Z","timestamp":1740509620000},"page":"103522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antibody immunotherapies for personalized opioid addiction treatment"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6084-8933","authenticated-orcid":false,"given":"Eric H.","family":"Rosenn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Korlansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4604-8993","authenticated-orcid":false,"given":"Shahin","family":"Benyaminpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Munarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eryn","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6438-3774","authenticated-orcid":false,"given":"Divyash","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7120-5176","authenticated-orcid":false,"given":"Andrea","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Less","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1524-5196","authenticated-orcid":false,"given":"Giulio Maria","family":"Pasinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103522_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.863734","article-title":"Inflammatory markers in substance use and mood disorders: a neuroimaging perspective","volume":"13","author":"Agarwal","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108511","article-title":"Chemokines, cytokines and substance use disorders","volume":"220","author":"Ahearn","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103522_bib3","first-page":"30","article-title":"Immunotherapy of 347 volunteer outpatient morphine addicts by human therapeutic morphine vaccine in Kermanshah province of Iran","volume":"4","author":"Akbarzadeh","year":"2009","journal-title":"J\u00a0Pharmacol Toxicol"},{"key":"10.1016\/j.jpet.2025.103522_bib4","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A\u00a0novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jpet.2025.103522_bib5","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/pharmaceutics13111779","article-title":"Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview","volume":"13","author":"Archie","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103522_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.111.076208","article-title":"Desensitization and trafficking of \u03bc-opioid receptors in locus ceruleus neurons: modulation by kinases","volume":"81","author":"Arttamangkul","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpet.2025.103522_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/cells9020506","article-title":"G-protein-coupled receptors in CNS: a potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits","volume":"9","author":"Azam","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jpet.2025.103522_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41386-018-0197-3","article-title":"Vaccines to treat opioid use disorders and to reduce opioid overdoses","volume":"44","author":"Baehr","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2025.103522_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.csbj.2022.12.021","article-title":"Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations","volume":"21","author":"Bai","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jpet.2025.103522_bib11","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/pharmaceutics13122014","article-title":"Current and emerging strategies for enhancing antibody delivery to the brain","volume":"13","author":"Bajracharya","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103522_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118052","article-title":"Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity","volume":"257","author":"Bakherad","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib13","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1080\/21645515.2021.1935171","article-title":"Synergistic immune and antinociceptive effects induced from the combination of two different vaccines against morphine\/heroin in mouse","volume":"17","author":"Barbosa-Mendez","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpet.2025.103522_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/pharmrev.121.000506","article-title":"Oxycodone: a current perspective on its pharmacology, abuse, and pharmacotherapeutic developments","volume":"75","author":"Barrett","year":"2023","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpet.2025.103522_bib15","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/acs.molpharmaceut.0c00497","article-title":"Novel vaccine that blunts fentanyl effects and sequesters ultrapotent fentanyl analogues","volume":"17","author":"Barrientos","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jpet.2025.103522_bib16","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.3233\/JAD-221070","article-title":"Untangling the role of TREM2 in conjugation with microglia in neuronal dysfunction: a hypothesis on a novel pathway in the pathophysiology of Alzheimer\u2019s disease","volume":"94","author":"Basha","year":"2023","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jpet.2025.103522_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/biom12020223","article-title":"A\u00a0stepwise framework for the systematic development of lipid nanoparticles","volume":"12","author":"Basso","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2025.103522_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/vaccines10060860","article-title":"Vaccines against drug abuse-are we there yet?","volume":"10","author":"Bloom","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jpet.2025.103522_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse, and treatment in the United States: an update","volume":"173","author":"Brady","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib21","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41467-023-43126-0","article-title":"Investigation of monoclonal antibody CSX-1004 for fentanyl overdose","volume":"14","author":"Bremer","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103522_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jpet.2025.103522_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.13.1","article-title":"Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse","volume":"12","author":"Brimijoin","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jpet.2025.103522_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103522_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2023.07.031","article-title":"Neuroimmune mechanisms of opioid use disorder and recovery: translatability to human studies, and future research directions","volume":"528","author":"Butelman","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpet.2025.103522_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-017-01881-x","article-title":"Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine","volume":"9","author":"Calipari","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103522_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/21548331.2022.2102776","article-title":"Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting","volume":"50","author":"Carswell","year":"2022","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/j.jpet.2025.103522_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/ITT.S370435","article-title":"A\u00a0review of immunotherapeutic approaches for substance use disorders: current status and future prospects","volume":"11","author":"Celik","year":"2022","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jpet.2025.103522_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood\u2013brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jpet.2025.103522_bib31","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1073\/pnas.0914733107","article-title":"Morphine peripheral analgesia depends on activation of the PI3Kgamma\/AKT\/nNOS\/NO\/KATP signaling pathway","volume":"107","author":"Cunha","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2025.103522_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/mol.112.079350","article-title":"Prolonged stimulation of \u03bc-opioid receptors produces \u03b2-arrestin-2-mediated heterologous desensitization of \u03b12-adrenoceptor function in locus ceruleus neurons","volume":"82","author":"Dang","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpet.2025.103522_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coi.2015.06.014","article-title":"Engineering humoral immunity as prophylaxis or therapy","volume":"35","author":"Deal","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jpet.2025.103522_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/vaccines9020108","article-title":"Advancements in mRNA encoded antibodies for passive immunotherapy","volume":"9","author":"Deal","year":"2021","journal-title":"Vaccines Basel"},{"key":"10.1016\/j.jpet.2025.103522_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858403259950","article-title":"Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance\/hyperalgesia","volume":"10","author":"DeLeo","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jpet.2025.103522_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.peptides.2019.01.003","article-title":"Inflammatory mediators of opioid tolerance: implications for dependency and addiction","volume":"115","author":"Eidson","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.jpet.2025.103522_bib37","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103522_bib38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.amepre.2023.11.024","article-title":"Drug use and artificial intelligence: weighing concerns and possibilities for prevention","volume":"66","author":"Ezell","year":"2024","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jpet.2025.103522_bib39","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/molecules25184257","article-title":"Biased opioid ligands","volume":"25","author":"Faouzi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103522_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fpsyt.2020.00220","article-title":"The promise of neuroimmune targets for treating drug addiction and other psychiatric disorders: granulocyte-colony stimulating factor exemplification","volume":"11","author":"Farokhnia","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.sbi.2018.04.007","article-title":"Computational design of antibodies","volume":"51","author":"Fischman","year":"2018","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.jpet.2025.103522_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12033-024-01064-2","article-title":"Revolutionizing synthetic antibody design: harnessing artificial intelligence and deep sequencing big data for unprecedented advances","volume":"67","author":"Gallo","year":"2025","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.jpet.2025.103522_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.1059089","article-title":"Mu-opioid receptor and receptor tyrosine kinase crosstalk: implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward","volume":"16","author":"Gamble","year":"2022","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib44","first-page":"251","article-title":"Immunotherapy for neurological diseases, present and future","volume":"42","author":"Ginestal-L\u00f3pez","year":"2018","journal-title":"Farm Hosp"},{"key":"10.1016\/j.jpet.2025.103522_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-021-02072-8","article-title":"Interactions of neuroimmune signaling and glutamate plasticity in addiction","volume":"18","author":"Gipson","year":"2021","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jpet.2025.103522_bib46","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1021\/acs.jctc.3c00513","article-title":"Computational methods in immunology and vaccinology: design and development of antibodies and immunogens","volume":"19","author":"Guarra","year":"2023","journal-title":"J\u00a0Chem Theory Comput"},{"key":"10.1016\/j.jpet.2025.103522_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107563","article-title":"Evidence for state, community and systems-level prevention strategies to address the opioid crisis","volume":"204","author":"Haegerich","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103522_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jpet.2025.103522_bib49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2012.04.031","article-title":"Activity-dependent growth of new dendritic spines is regulated by the proteasome","volume":"74","author":"Hamilton","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jpet.2025.103522_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","article-title":"The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies","volume":"9","author":"Han","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.phrs.2018.11.012","article-title":"Prefrontal-accumbens opioid plasticity: implications for relapse and dependence","volume":"139","author":"Hearing","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jpet.2025.103522_bib52","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.1014768","article-title":"Endogenous opioid systems alterations in pain and opioid use disorder","volume":"16","author":"Higginbotham","year":"2022","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib54","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.114.4.1363","article-title":"Delayed clearance of morphine from the circulation of rabbits immunized with morphine-6-hemisuccinate bovine serum albumin","volume":"114","author":"Hill","year":"1975","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jpet.2025.103522_bib55","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1111\/ejn.14143","article-title":"Neuroimmune mechanisms of psychostimulant and opioid use disorders","volume":"50","author":"Hofford","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib56","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/vaccines10111778","article-title":"Immunotherapies for the treatment of drug addiction","volume":"10","author":"Hossain","year":"2022","journal-title":"Vaccines Basel"},{"key":"10.1016\/j.jpet.2025.103522_bib57","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.3390\/ijms25147781","article-title":"Opioid-based haptens: development of immunotherapy","volume":"25","author":"Hosztafi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib58","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s12264-023-01059-0","article-title":"Blockade of the dopamine D3 receptor attenuates opioids-induced addictive behaviours associated with inhibiting the mesolimbic dopamine system","volume":"39","author":"Hu","year":"2023","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jpet.2025.103522_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","article-title":"Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor","volume":"7","author":"Hultqvist","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jpet.2025.103522_bib60","first-page":"43234","article-title":"Hapten-based vaccination as an innovative therapeutic approach for drug addiction","volume":"52","author":"Husni","year":"2023","journal-title":"Biomed J Sci Tech Res"},{"key":"10.1016\/j.jpet.2025.103522_bib61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14712598.2020.1745770","article-title":"A\u00a0review of antibody-based therapeutics targeting G protein-coupled receptors: an update","volume":"20","author":"Hutchings","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jpet.2025.103522_bib62","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbi.2008.05.004","article-title":"Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpet.2025.103522_bib63","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing efficacy and stability of an antiheroin vaccine: examination of antinociception, opioid binding profile, and lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jpet.2025.103522_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2023.12.041","article-title":"Nogo-A neutralization in the central nervous system with a blood-brain barrier-penetrating antibody","volume":"366","author":"Joly","year":"2024","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jpet.2025.103522_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12987-022-00398-w","article-title":"Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer\u2019s disease mice measured by high cut-off microdialysis","volume":"19","author":"Julku","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jpet.2025.103522_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/vaccines11030661","article-title":"Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications","volume":"11","author":"Karunakaran","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jpet.2025.103522_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/bs.apha.2021.09.002","article-title":"Potential therapeutic targets for the treatment of opioid abuse and pain","volume":"93","author":"Kiguchi","year":"2022","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jpet.2025.103522_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2022.4020","article-title":"Clinical trial design challenges and opportunities for emerging treatments for opioid use disorder: a review","volume":"80","author":"Kiluk","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1045","article-title":"A\u00a0humanized anti-cocaine mAb antagonizes the cardiovascular effects of cocaine in rats","volume":"11","author":"Koch","year":"2023","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jpet.2025.103522_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103522_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A\u00a0morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib71","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/cells9112400","article-title":"GRKs as key modulators of opioid receptor function","volume":"9","author":"Lemel","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jpet.2025.103522_bib72","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/s41380-024-02443-6","article-title":"Microglia in neuroimmunopharmacology and drug addiction","volume":"29","author":"Li","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A\u00a0morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jpet.2025.103522_bib74","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/acsptsci.3c00031","article-title":"Catalytic antibody blunts carfentanil-induced respiratory depression","volume":"6","author":"Lin","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11011-020-00630-2","article-title":"Crossing the blood-brain barrier with AAV vectors","volume":"36","author":"Liu","year":"2021","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jpet.2025.103522_bib76","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/bph.14922","article-title":"Morphine-induced RACK1-dependent autophagy in immortalized neuronal cell lines","volume":"177","author":"Liu","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103522_bib77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/pharmaceutics16010084","article-title":"Vaccines to treat substance use disorders: current status and future directions","volume":"16","author":"Lu","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103522_bib78","first-page":"368","article-title":"[Preparation and characterization of anti-morphine vaccine antibody]","volume":"22","author":"Ma","year":"2006","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.jpet.2025.103522_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110210","article-title":"Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction","volume":"119","author":"Malik","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jpet.2025.103522_bib80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/00952990.2023.2248646","article-title":"Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample","volume":"49","author":"Mannes","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jpet.2025.103522_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.870799","article-title":"AAV vector-mediated antibody delivery (A-MAD) in the central nervous system","volume":"13","author":"Marino","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jpet.2025.103522_bib82","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809824","article-title":"AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer\u2019s disease model","volume":"14","author":"Marino","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jpet.2025.103522_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Mendon\u00e7a","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2025.103522_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jpet.2025.103522_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.650785","article-title":"Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities","volume":"15","author":"Namba","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jnc.12725","article-title":"mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse","volume":"130","author":"Neasta","year":"2014","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jpet.2025.103522_bib87","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/17460441.2010.525633","article-title":"Emerging concepts and approaches for chemokine-receptor drug discovery","volume":"5","author":"O\u2019Hayre","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.jpet.2025.103522_bib88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/ph14060535","article-title":"Mathematical models of blood-brain barrier transport of monoclonal antibodies targeting the transferrin receptor and the insulin receptor","volume":"14","author":"Pardridge","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2025.103522_bib89","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jpet.2025.103522_bib90","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1080\/21645515.2016.1212785","article-title":"Biologics to treat substance use disorders: current status and new directions","volume":"12","author":"Pravetoni","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpet.2025.103522_bib91","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jpet.2025.103522_bib92","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2025.103522_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108653","article-title":"Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder","volume":"195","author":"Raleigh","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103522_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103522_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2022.899637","article-title":"A\u00a0glitch in the matrix: the role of extracellular matrix remodeling in opioid use disorder","volume":"16","author":"Ray","year":"2022","journal-title":"Front Integr Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fnins.2015.00399","article-title":"Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation","volume":"9","author":"Rosen","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib98","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/immuno3030021","article-title":"Monoclonal war: the antibody arsenal and targets for expanded application","volume":"3","author":"Rosenn","year":"2023","journal-title":"Immuno"},{"key":"10.1016\/j.jpet.2025.103522_bib99","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1039\/D1NA00712B","article-title":"Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing","volume":"4","author":"Sarode","year":"2022","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.jpet.2025.103522_bib100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103522_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12938-022-01062-y","article-title":"Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience","volume":"22","author":"Shabani","year":"2023","journal-title":"Biomed Eng Online"},{"key":"10.1016\/j.jpet.2025.103522_bib102","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances beta-amyloid plaque clearance in the 5XFAD Alzheimer\u2019s disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-021-00329-0","article-title":"Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge","volume":"6","author":"Stone","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jpet.2025.103522_bib104","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A\u00a0vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jpet.2025.103522_bib105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.chom.2022.01.003","article-title":"Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections","volume":"30","author":"Terreri","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jpet.2025.103522_bib106","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00213-022-06144-2","article-title":"Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats","volume":"239","author":"Ucha","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpet.2025.103522_bib107","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3389\/fimmu.2020.01951","article-title":"The molecular mechanisms that underlie the immune biology of anti-drug antibody formation following treatment with monoclonal antibodies","volume":"11","author":"Vaisman-Mentesh","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103522_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13184","article-title":"Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies","volume":"34","author":"Vallat","year":"2024","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jpet.2025.103522_bib109","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","article-title":"Targeted nanomedicine: lessons learned and future directions","volume":"355","author":"Veiga","year":"2023","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jpet.2025.103522_bib110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10799893.2016.1147584","article-title":"Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases","volume":"36","author":"Verma","year":"2016","journal-title":"J\u00a0Recept Signal Transduct Res"},{"key":"10.1016\/j.jpet.2025.103522_bib111","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpet.2025.103522_bib112","article-title":"Correction: development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design","volume":"13","author":"Wada","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103522_bib113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.coche.2013.08.005","article-title":"Back to the future: recombinant polyclonal antibody therapeutics","volume":"2","author":"Wang","year":"2013","journal-title":"Curr Opin Chem Eng"},{"key":"10.1016\/j.jpet.2025.103522_bib114","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2025.103522_bib115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tins.2005.10.001","article-title":"Glia: novel counter-regulators of opioid analgesia","volume":"28","author":"Watkins","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpet.2025.103522_bib116","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1038\/s41467-023-41455-8","article-title":"Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder","volume":"14","author":"Wei","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103522_bib117","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7150\/ijbs.6426","article-title":"Glutamate, glutamate receptors, and downstream signaling pathways","volume":"9","author":"Willard","year":"2013","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207027","article-title":"A\u00a0computational strategy for finding novel targets and therapeutic compounds for opioid dependence","volume":"13","author":"Wu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103522_bib119","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.lfs.2013.04.006","article-title":"PKA and ERK1\/2 are involved in dopamine D1 receptor-induced heterologous desensitization of the \u03b4 opioid receptor","volume":"92","author":"Xu","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-0716-2609-2_4","article-title":"Molecular dynamics simulation for investigating antigen-antibody interaction","volume":"2552","author":"Yamashita","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jpet.2025.103522_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4865","article-title":"Evaluation of AlphaFold antibody-antigen modeling with implications for improving predictive accuracy","volume":"33","author":"Yin","year":"2024","journal-title":"Protein Sci"},{"key":"10.1016\/j.jpet.2025.103522_bib123","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.vaccine.2015.09.079","article-title":"Is immunotherapy an opportunity for effective treatment of drug addiction?","volume":"33","author":"Zalewska-Kaszubska","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jpet.2025.103522_bib124","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2019.11.012","article-title":"Glial neuroimmune signaling in opioid reward","volume":"155","author":"Zhang","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jpet.2025.103522_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jpet.2025.103522_bib127","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1158\/1078-0432.CCR-18-2752","article-title":"Targeting multiple myeloma with AMG 424, a novel anti-CD38\/CD3 bispecific T-cell-recruiting antibody optimized for cytotoxicity and cytokine release","volume":"25","author":"Zuch de Zafra","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:33:21Z","timestamp":1762209201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525397351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022356525397351"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103522","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody immunotherapies for personalized opioid addiction treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103522"}}